This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the ...

According to Credence Research, the CAR-T Cell Therapy Market is set to witness robust growth, advancing from USD 4,405 million in 2024 to USD 11,142.53 million by 2032. This expansion represents a ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

CAR T-cells are a type of modified T cells from the immune system, designed to recognize and eliminate cancerous cells, a more selective approach compared to the general killing of infectious cells ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

Hospitals and research institutes in Guangzhou, Guangdong province, are expanding the clinical use of cell and gene therapies ...